News

Dara BioSciences said that the study will enroll approximately 75 volunteers and will be conducted at Quintiles’ Overland Park facility. The study’s main objectives are to determine the

Æterna Zentaris has posted a net income of $12.03m, or $0.19 per diluted share, compared to net loss of $14.49m, or $0.27 per diluted share, for the prior

The distribution agreement, announced in conjunction with positive data presented at the 7th European Breast Cancer Conference (EBCC), further expands the global presence of Oncotype DX, providing for

Alogliptin (once daily dosing) was discovered by Takeda’s wholly-owned subsidiary Takeda San Diego and is a member of the dipeptidyl peptidase IV (DPP-4) inhibitors class. DPP-4 selectively metabolizes

Cedax was originally discovered by Shionogi and Co and licensed to Schering-Plough. Cedax had received marketing approval from the FDA in 1995. Indicated for mild to moderate acute

Phico has raised more than GBP3.7m during the last 12 months, bringing the total investment in the company to date to approximately GBP9m. Phico’s technology, known as SASPject,

Velaglucerase alfa is manufactured in Shire’s facility in Cambridge MA, which was inspected and approved by the FDA for the commercial production of VPRIV. VPRIV was approved by

Bosch Packaging said that the new MHI 2020 vial filling and closing machine is specifically designed to handle liquid pharmaceuticals in small batches, making it ideal for clinical

BioStorage Technologies’ facilities will offer its clients the option to utilise Biomatrica’s dry storage technology, which provides security-controlled storage and ensures a stable humidity environment for samples. In